Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (231-240 of 565) with videos related to

Pageof 57
Sort By:
Journal of the American Geriatrics Society|December 13, 2012
Association between tea consumption and depressive symptoms in older Chinese adultsLei Feng, Jialiang Li, Ee-Heok Kua, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression studyRoy H Perlis, Renerio Fraguas, Maurizio Fava, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 20, 2005
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLMaurizio Fava, A John Rush, Michael E Thase, et al.
International Journal of Methods in Psychiatric Research|August 25, 2009
Release bias in accessing medical records in clinical trials: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2011
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trialEdward S Friedman, Lori L Davis, Sidney Zisook, et al.
American Journal of Nephrology|June 6, 2019
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney OutcomesL Parker Gregg, Nishank Jain, Thomas Carmody, et al.
Frontiers in Neuroscience|August 8, 2022
Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety-A Role for Bile AcidsSiamak MahmoudianDehkordi, Sudeepa Bhattacharyya, Christopher R Brydges, et al.
General Hospital Psychiatry|October 18, 2011
Effects of heart disease on depression treatment: results from the COMED studyKevin Brian Kerber, Stephen R Wisniewski, James F Luther, et al.
Neuropsychiatric Disease and Treatment|July 23, 2021
Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D ReportAugustus John Rush, Charles South, Shailesh Jain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 29, 2021
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trialNikita van der Vinne, Madelon A Vollebregt, A John Rush, et al.
Pageof 57

Showing results (231-240 of 565) with videos related to

Sort By:
Pageof 57
Journal of the American Geriatrics Society|December 13, 2012
Association between tea consumption and depressive symptoms in older Chinese adultsLei Feng, Jialiang Li, Ee-Heok Kua, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression studyRoy H Perlis, Renerio Fraguas, Maurizio Fava, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 20, 2005
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLMaurizio Fava, A John Rush, Michael E Thase, et al.
International Journal of Methods in Psychiatric Research|August 25, 2009
Release bias in accessing medical records in clinical trials: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 17, 2011
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trialEdward S Friedman, Lori L Davis, Sidney Zisook, et al.
American Journal of Nephrology|June 6, 2019
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney OutcomesL Parker Gregg, Nishank Jain, Thomas Carmody, et al.
Frontiers in Neuroscience|August 8, 2022
Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety-A Role for Bile AcidsSiamak MahmoudianDehkordi, Sudeepa Bhattacharyya, Christopher R Brydges, et al.
General Hospital Psychiatry|October 18, 2011
Effects of heart disease on depression treatment: results from the COMED studyKevin Brian Kerber, Stephen R Wisniewski, James F Luther, et al.
Neuropsychiatric Disease and Treatment|July 23, 2021
Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D ReportAugustus John Rush, Charles South, Shailesh Jain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 29, 2021
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trialNikita van der Vinne, Madelon A Vollebregt, A John Rush, et al.
Pageof 57